re: Ann: Signing of Detailed Joint Venture Ag... Paying 91% for 70% share. They may as well make a takeover offer, and take the whole lot.I guess that may come down the track once they can use BRL to get it all set up
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
